1. Market Research

PharmaSphere: Emerging Biotech Investment Report - Strategic Trends in Private Equity and Venture Capital Funding

  • March 2014
  • 183 pages
  • GlobalData
Report ID: 2051417

Summary

Table of Contents

PharmaSphere: Emerging Biotech Investment Report - Strategic Trends in Private Equity and Venture Capital Funding

Summary

GlobalData’s "PharmaSphere: Emerging Biotech Investment Report - Strategic Trends in Private Equity and Venture Capital Funding" report provides in-depth analysis of the current trends and factors shaping the private equity and venture capital segments of the financial industry, bearing in mind that these are expected to have significant impact on the future of emerging biotechnology companies in the US and globally. Furthermore, the report identifies regions of the world that are attracting more investments in healthcare and discusses the various factors responsible for this trend. In addition, the report provides detailed profiles of 12 leading private equity firms, 15 top venture capital firms, and 15 US-based emerging biotechnology companies that completed initial public offerings in 2013.

Throughout the report, GlobalData’s analysts provide you with expert insight, expanding on each observation, strategy, and trend discussed, with the aim of providing you with the tools needed for making informed business decisions in the rapidly changing global investment landscape.

Highlights

Key Questions Answered

- What are the current trends impacting emerging biotechnology investment in the US and globally?
- What regions are witnessing noteworthy investment in healthcare and what are the factors driving such occurrences?
- What therapeutic areas are attracting the most investment by private equity and venture capital firms and why?
- What has been the trend of equity offerings in the healthcare sector since 2004 and what factors were responsible?
- What is the strategic outlook of emerging biotechnology investment?

About the Report

This report is an essential source of information and analysis on emerging biotech investment, with significant emphasis on the US. GlobalData provides an in-depth analysis of the current trends and factors shaping the private equity and venture capital segments of the financial industry. The report highlights the various therapeutic areas attracting noteworthy funding in terms of the volume and value of new and follow-on investments and discusses the factors responsible for this trend. Furthermore, it provides a strategic outlook on future trends that are expected in private equity and venture capital funding and how they will impact the growth and development of biotech companies globally.

Scope

- Historical trend analysis of private equity and venture capital funding prior to- and after the financial market crash of 2008, including a change in the average value of completed deals in the healthcare industry
- The report highlights how ongoing healthcare reform in parts of Europe and North America are resulting in a shift of deals activity involving private equity and venture capital firms to the Asia-Pacific
- Discussion of therapeutic areas attracting significant investments, as well as the factors responsible for such trends
- Detailed profiles of 12 leading private equity firms, 15 top venture capital firms, and 15 US-based emerging biotechnology companies that completed initial public offerings in 2013
- Global strategic outlook on future trends that are expected in private equity and venture capital funding, as well as the need for a new financing model to drive the sustainable growth of emerging biotech companies.

Reasons to buy

- Understand the current trends impacting emerging biotechnology investment in the US and globally
- Evaluate the strategies being used by leading private equity and venture capital firms as they aim to minimize risk and ensure significant return on investment
- Gain valuable insights into the investment strategies, deals, and portfolios of leading private equity and venture capital firms
- Gain valuable insights into US-based, innovative emerging biotechnology companies with venture capital backing, their developmental pipelines, and strategic collaborations
- Use this information as an independent source for your due diligence and transaction strategy

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Amrita helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.